<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Molecular Cloning | Protocol 10 Print Version</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1251"><!--================== Designed and Developed by WriteDesign =================--><!--======================= Powered by RomeBlack, Inc. =======================--><!--=== Copyright 2000, 2001 Cold Spring Harbor Labs. All Rights Reserved. ===-->
<META content="" name=keywords>
<META 
content="3&acute;-RACE reactions are used to isolate unknown 3&acute; sequences or to map the 3&acute; termini of mRNAs onto a gene sequence. 3&acute;-RACE requires knowledge of a small region of sequence within either the target RNA or a partial clone of cDNA. A population of mRNAs is transcribed into cDNA with an adaptor-primer consisting at its 3&acute; end of a poly(T) tract and at its 5&acute; end of an arbitrary sequence of 30-40 nucleotides. Reverse transcription is usually followed by two successive PCRs. The first is primed by a gene-specific sense oligonucleotide and an antisense primer complementary to the arbitrary sequence in the (dT)adaptor-primer. If necessary, the products of the first PCR can be used as templates for a second nested PCR, which is primed by a gene-specific sense oligonucleotide internal to the first, and a second antisense oligonucleotide complementary to the central region of the (dT)adaptor-primer. The products amplified in the second PCR are isolated from an agarose gel, cloned, and characterized. To reduce the chance of contamination with exogenous DNAs, prepare and use a special set of reagents and solutions for PCR only. Bake all glassware for 6 hours at 150°C and autoclave all plasticware." 
name=description>
<META content="MSHTML 5.50.4134.600" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff background=../izo/fon.gif>
<table width=600 border="0" cellspacing="0" cellpadding="0"><tr><td width=600><IMG height=49 hspace=4 src="../izo/logo_csh.gif" 
width=169 align=left vspace=4><IMG height=49 hspace=4 
src="../izo/print_header.gif" width=293 align=left vspace=4><BR 
clear=all><BR><FONT face="arial,verdana, helvetica" size=4><STRONG>Chapter 8, 
Protocol 10</STRONG></FONT><BR><BR clear=all><FONT face=arial,verdana,helvetica 
size=3><STRONG>Rapid Amplification of 3&acute;cDNA Ends 
(3&acute;-RACE)</STRONG></FONT><BR><BR><FONT face="arial,verdana, helvetica" 
size=2>3&acute;-RACE reactions are used to isolate unknown 3&acute; sequences or to map the 
3&acute; termini of mRNAs onto a gene sequence. 3&acute;-RACE requires knowledge of a small 
region of sequence within either the target RNA or a partial clone of cDNA. A 
population of mRNAs is transcribed into cDNA with an adaptor-primer consisting 
at its 3&acute; end of a poly(T) tract and at its 5&acute; end of an arbitrary sequence of 
30-40 nucleotides. Reverse transcription is usually followed by two successive 
PCRs. The first is primed by a gene-specific sense oligonucleotide and an 
antisense primer complementary to the arbitrary sequence in the 
(dT)adaptor-primer. If necessary, the products of the first PCR can be used as 
templates for a second nested PCR, which is primed by a gene-specific sense 
oligonucleotide internal to the first, and a second antisense oligonucleotide 
complementary to the central region of the (dT)adaptor-primer. The products 
amplified in the second PCR are isolated from an agarose gel, cloned, and 
characterized. To reduce the chance of contamination with exogenous DNAs, 
prepare and use a special set of reagents and solutions for PCR only. Bake all 
glassware for 6 hours at 150°C and autoclave all plasticware.</FONT> <BR><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD width=700><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" 
      width=11 border=0><FONT face=arial,verdana,helvetica 
      size=2><STRONG>CAUTION</STRONG></FONT><BR><IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0><FONT 
      face="arial,verdana, helvetica" size=2> <STRONG>RECIPE</STRONG></FONT> 
  </TD></TR></TBODY></TABLE><BR><BR><FONT face=arial,verdana,helvetica 
size=3><STRONG>MATERIALS</STRONG></FONT><BR><BR>
<TABLE cellPadding=0 cellborder="0">
  <TBODY>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Buffers and Solutions</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>10x 
      Amplification buffer</FONT> <IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Chloroform 
      </FONT><IMG height=11 alt=caution hspace=4 src="../izo/triangle.gif" 
      width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>dNTP solution 
      (20 mM) containing all four dNTPs (pH 8.0)</FONT> <IMG height=12 alt="" 
      hspace=4 src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Placental 
      RNase inhibitor (20 units/µl)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>TE (pH 
      7.6)</FONT> <IMG height=12 alt="" hspace=4 src="../izo/circle.gif" 
      width=12 border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Enzymes and Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Reverse 
      transcriptase (RNA-dependent DNA polymerase)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>5x Reverse 
      transcriptase buffer</FONT> <IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Thermostable 
      DNA polymerase</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Taq<I> DNA 
      polymerase is the standard and appropriate enzyme for the amplification 
      stage of most forms of RT-PCR. However, where elongation from 
      3&acute;-mismatched primers is suspected, a thermostable DNA polymerase with 
      3&acute;-&gt;5&acute; proofreading activity may be preferred.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Nucleic Acids and Oligonucleotides</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Adaptor-primer 
      (10 µM) (5&acute; GACTCGAGTCGACATCG 3&acute;) in H<SUB>2</SUB>O (10 pmoles/µl).</FONT> 
    </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>The 
      adaptor-primer is used in conjunction with a gene-specific sense primer to 
      amplify a particular target cDNA.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" 
      size=2>(dT)<SUB>17</SUB>-Adaptor-primer (10 µM) (5&acute; 
      GACTCGAGTCGACATCGA(T)<SUB>17</SUB> 3&acute;) in H<SUB>2</SUB>O (10 
      pmoles/µl).</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>The 
      oligo(dT) region of the (dT)<SUB>17</SUB>-adaptor antisense primer binds 
      to the poly(A)<SUP>+</SUP> tract at the 3&acute; end of mRNA, leaving the 
      adaptor sequences unpaired. During amplification, the adaptor sequences 
      are converted to double-stranded cDNA that, in the example given in this 
      protocol, is equipped with recognition sites for </I>Xho<I>I, </I>Sal<I>I, 
      </I>Acc<I>I, </I>Hin<I>cII</I>, and Cla<I>I</I> restriction 
      enzymes.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Gene-specific 
      sense oligonucleotide primer (10 µM) in H<SUB>2</SUB>O (10 
      pmoles/µl).</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>The 
      gene-specific sense primer should encode a known region of sequence of the 
      target mRNA, should be 20-30 nucleotides in length, and contain 
      approximately equal numbers of the four bases, with a balanced 
      distribution of G and C residues and a low propensity to form stable 
      secondary structures. Restriction sites can be incorporated into the 
      gene-specific oligonucleotides to facilitate cloning.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Template 
      RNA.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Template 
      RNA may be total RNA (100 µg/ml) in H<SUB>2</SUB>O or poly(A)<SUP>+</SUP> 
      RNA (10 µg/ml) in H<SUB>2</SUB>O. Total RNA extracted from cells with 
      chaotropic agents is generally the template of choice for RT-PCR for mRNAs 
      that are expressed at moderate to high abundance. Poly(A)<SUP>+</SUP> is 
      preferred as a template for all forms of RT-PCR when the target mRNA is 
      expressed at low abundance.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Additional Reagents</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 6 of this 
      protocol requires the reagents listed in <A href="../05/02.htm">Chapter 
      5, Protocol 2 </A>, <A href="../12/06.htm">Chapter 
      12, Protocol 6</A>, or <A href="../06/10.htm">Chapter 
      6, Protocol 10 </A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 8 of this 
      protocol requires the reagents listed in <A href="03.htm">Chapter 
      8, Protocol 3 </A>and <A href="04.htm">Chapter 
      8, Protocol 4 </A>, <A href="05.htm">Chapter 
      8, Protocol 5 </A>, or <A href="06.htm">Chapter 
      8, Protocol 6. </A></FONT></TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 
  border=0></TD></TR></TBODY></TABLE><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" 
size=3><STRONG>METHOD</STRONG></FONT> <BR><FONT face="arial,verdana, helvetica" 
color=#000000 size=2>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Transfer 1 pg 
  to 100 ng of poly(A)<SUP>+</SUP> mRNA or 10 pg to 1 µg of total RNA to a fresh 
  microfuge tube. Adjust the volume to 10 µl with H<SUB>2</SUB>O. Denature the 
  RNA by heating at 75°C for 5 minutes, followed by rapid chilling on ice. 
  </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>To the 
  denatured RNA add: 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>5x reverse 
        transcriptase buffer</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>20 mM solution 
        of four dNTPs</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1.5 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10 µM 
        (dT)<SUB>17</SUB>-adaptor-primer (80 pmoles)</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>8.0 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>approx. 20 
        units/µl placental RNase inhibitor</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>100-200 
        units/µl reverse transcriptase</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
        size=2>H<SUB>2</SUB>O</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>to 50 
      µl</FONT></TD></TR></TBODY></TABLE>Incubate the reaction for 60 minutes at 
  37°C. Set up three negative control reactions. In one reaction, include all of 
  the components of the first-strand reaction, except the RNA template. In 
  another reaction, include all of the components, except the reverse 
  transcriptase. Omit primer from the third reaction. Carry the controls through 
  all subsequent steps of the protocol.<BR><I>Total cDNA synthesis can be 
  estimated from the proportion of TCA-precipitable radioactivity incorporated 
  in reverse transcriptase reactions supplemented with 10-20 µCi of 
  [<SUP>32</SUP>P]dCTP (sp. act. 3000 Ci/mmole). Be sure to set up a control 
  reaction that contains no (dT)<SUB>17</SUB> adaptor antisense 
  primer.</I><BR><I>The success or failure of 3&acute;-RACE is determined here. If the 
  reverse transcription step works efficiently, the chance of isolating clones 
  that contain the 3&acute;-terminal sequences of the target mRNA is high. On the 
  other hand, no amount of work on the later steps of the protocol can 
  compensate for ineffective reverse transcription. It is therefore worthwhile 
  to take the time to optimize the reverse transcriptase reaction by determining 
  the optimum ratio of primer to template for each preparation of RNA and by 
  varying the concentration of Mg<SUP>2+</SUP> in the reaction.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Dilute the 
  reverse transcriptase reaction (cDNA) to a final volume of 1 ml with TE (pH 
  7.6).<BR><I>It may be necessary to remove excess oligonucleotide and random 
  hexamer primers from the cDNA preparation and then to optimize the 
  concentrations of the sense and antisense primers in the amplification 
  reaction (please see Step 3 of <A href="09.htm">Chapter 
  8, Protocol 9</A>).</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>In a sterile 
  0.5-ml microfuge tube, amplification tube, or the well of a sterile microtiter 
  plate, set up a series of PCRs containing the following: 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>diluted 
        cDNA</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>0-20 
      µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10x 
        amplification buffer</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>5 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>20 mM solution 
        of four dNTPs</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>5 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10 µM 
        (dT)<SUB>17</SUB>-adaptor-primer (16 pmoles)</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1.6 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10 µM 
        adaptor-primer (32 pmoles)</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>3.2 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10 µM 
        gene-specific, sense oligonucleotide primer (32 pmoles)</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>3.2 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1-2 units 
        thermostable DNA polymerase</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
        size=2>H<SUB>2</SUB>O</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>to 50 
      µl</FONT></TD></TR></TBODY></TABLE><I>It is essential to set up a series of 
  amplification reactions to find the amount of cDNA that generates the largest 
  quantity of amplified 3&acute; termini. The control containing no cDNA template 
  serves as a control for contamination.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>If the thermal 
  cycler is not fitted with a heated lid, overlay the reaction mixtures with 1 
  drop (approx. 50 µl) of light mineral oil. Alternatively, place a bead of 
  paraffin wax into the tube if using a hot start protocol. Place the tubes or 
  the microtiter plate in the thermal cycler. Amplify the nucleic acids using 
  the denaturation, annealing, and polymerization times and temperatures listed 
  in the table. 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2><B>Cycle 
        Number</B></FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
        size=2><B>Denaturation</B></FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
        size=2><B>Annealing</B></FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
        size=2><B>Polymerization</B></FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>First 
        Cycle</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>5 min at 
        94°C</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>5 min at 
        50-58°C</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>40 min at 
        72°C</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Subsequent 
        cycles (20)</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>40 sec at 
        94°C</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 min at 
        50-58°C</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>3 min at 
        72°C</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Last 
        cycle</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>40 sec at 
        94°C</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 min at 
        50-58°C</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>15 min at 
        72°C</FONT></TD></TR></TBODY></TABLE><I>Times and temperatures may need to be 
  adapted to suit the particular reaction conditions.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Withdraw a 
  sample (5-10 µl) from the test reaction mixture and the four control reactions 
  and analyze them by electrophoresis through an agarose or polyacrylamide gel. 
  Include DNA markers of an appropriate size. Stain the gel with ethidium 
  bromide or SYBR Gold to visualize the DNA.<BR><I>A successful amplification 
  reaction should yield a readily visible DNA fragment of the expected size. The 
  identity of the band can be confirmed by DNA sequencing (please see <A href="../12/06.htm">>Chapter 
  12, Protocol 6</A>), Southern hybridization (please see <A href="../06/10.htm">Chapter 
  6, Protocol 10 </A>), and/or restriction mapping.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>If mineral oil 
  was used to overlay the sample, remove the oil from the sample before cloning 
  by extraction with 150 µl of chloroform.<BR><I>The aqueous phase, which 
  contains the amplified DNA, will form a micelle near the meniscus. The micelle 
  can be transferred to a fresh tube with an automatic 
  micropipette.</I><BR><B>IMPORTANT</B> <I>Do not attempt chloroform extractions 
  in microtiter plates. The plastic used in these plates in not resistant to 
  organic solvents.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Separate the 
  amplified DNA from the residual thermostable DNA polymerase and dNTPs (please 
  see <A href="../06/10.htm">Chapter 
  6, Protocol 10 </A>).<BR><I>The DNA can now be ligated to a blunt-ended vector 
  or a T vector, or it can digested with restriction enzymes and ligated to a 
  vector with compatible termini (please see <A href="04.htm">Chapter 
  8, Protocol 4 </A>, <A href="05.htm">Chapter 
  8, Protocol 5 </A>, and <A href="06.htm">Chapter 
  8, Protocol 6 </A>).</I> </FONT></LI></OL></FONT><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>RECIPES</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/circle.gif" width=12 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Amplification Buffer</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>500 mM KCl</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>100 mM Tris-Cl (pH 8.3 at 
      room temperature)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>15 mM 
      MgCl<SUB>2</SUB></FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Autoclave the 10x buffer 
      for 10 minutes at 15 psi (1.05 kg/cm <SUP>2</SUP>) on liquid cycle. Divide 
      the sterile buffer into aliquots and store them at 
  -20°C.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>EDTA</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare EDTA at 0.5 M 
      (pH 8.0): Add 186.1 g of disodium EDTA2H<SUB>2</SUB>O to 800 ml of 
      H<SUB>2</SUB>O. Stir vigorously on a magnetic stirrer. Adjust the pH to 
      8.0 with NaOH (approx. 20 g of NaOH pellets). Dispense into aliquots and 
      sterilize by autoclaving. The disodium salt of EDTA will not go into 
      solution until the pH of the solution is adjusted to approx. 8.0 by the 
      addition of NaOH.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>KCl</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Dissolve an appropriate 
      amount of solid KCl in H<SUB>2</SUB>O, autoclave for 20 minutes on liquid 
      cycle and store at room temperature. Ideally, this 4 M solution should be 
      divided into small (approx. 100 µl) aliquots in sterile tubes and each 
      aliquot thereafter used one time.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Reverse Transcriptase Buffer</STRONG></FONT> 
    </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>500 mM Tris-Cl (pH 
      8.3)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>750 mM KCl</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>30 mM 
      MgCl<SUB>2</SUB></FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10x 
  stock.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>TE</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>100 mM Tris-Cl (desired 
      pH)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10 mM EDTA (pH 
    8.0)</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>(10x Tris EDTA) Sterilize 
      solutions by autoclaving for 20 minutes at 15 psi (1.05 kg/cm 
      <SUP>2</SUP>) on liquid cycle. Store the buffer at room 
    temperature.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Tris-Cl</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Dissolve 121.1 g of Tris base in 800 ml of H<SUB>2</SUB>O. Adjust the 
      pH to the desired value by adding concentrated HCl.</P>
      <TABLE>
        <TBODY>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2><I>pH</I></FONT> </TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2><I>HCl</I></FONT> 
        </TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>7.4 </FONT></TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2>70 ml </FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>7.6 </FONT></TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2>60 ml </FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>8.0 </FONT></TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2>42 ml 
        </FONT></TD></TR></TBODY></TABLE>
      <P>(1 M) Allow the solution to cool to room temperature before making 
      final adjustments to the pH. Adjust the volume of the solution to 1 liter 
      with H<SUB>2</SUB>O. Dispense into aliquots and sterilize by 
      autoclaving.</P>
      <P>If the 1 M solution has a yellow color, discard it and obtain Tris of 
      better quality. The pH of Tris solutions is temperature-dependent and 
      decreases approx. 0.03 pH units for each 1°C increase in temperature. For 
      example, a 0.05 M solution has pH values of 9.5, 8.9, and 8.6 at 5°C, 
      25°C, and 37°C, respectively.</P></FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>dNTP Solution</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Dissolve each dNTP (deoxyribonucleoside triphosphates) in 
      H<SUB>2</SUB>O at an approximate concentration of 100 mM. Use 0.05 M Tris 
      base and a micropipette to adjust the pH of each of the solutions to 7.0 
      (use pH paper to check the pH). Dilute an aliquot of the neutralized dNTP 
      appropriately, and read the optical density at the wavelengths given in 
      the table below. Calculate the actual concentration of each dNTP. Dilute 
      the solutions with H<SUB>2</SUB>O to a final concentration of 50 mM dNTP. 
      Store each separately at -70°C in small aliquots. For polymerase chain 
      reactions (PCRs), adjust the dNTP solution to pH 8.0 with 2 N NaOH. 
      Commercially available solutions of PCR-grade dNTPs require no 
      adjustment.</P>
      <P>
      <TABLE width=400>
        <TBODY>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>Base</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana 
            size=2>wavelength<BR>(nm)</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>Extinction 
            Coefficient<BR>(E)&nbsp;(M<SUP>-1</SUP>cm<SUP>-1</SUP>)</FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>A</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>259</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>1.54 x 
            10<SUP>4</SUP></FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>G</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>253</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>1.37 x 
            10<SUP>4</SUP></FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>C</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>271</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>9.10 x 
            10<SUP>3</SUP></FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>T</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>267</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>9.60 x 
            10<SUP>3</SUP></FONT></TD></TR></TBODY></TABLE></P>
      <P>For a cuvette with a path length of 1 cm, absorbance = EM. 100 mM stock 
      solutions of each dNTP are commercially available 
    (Pharmacia).</P></FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;     helvetica" size=3><STRONG>CAUTIONS</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" width=11 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>Chloroform</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">Chloroform CHCl<SUB>3</SUB> is irritating to the skin, eyes, 
      mucous membranes, and respiratory tract. It is a carcinogen and may damage 
      the liver and kidneys. It is also volatile. Avoid breathing the vapors. 
      Wear appropriate gloves and safety glasses. Always use in a chemical fume 
      hood. </FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>REFERENCES</STRONG> 
</FONT><BR>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Bespalova I.N., 
  Adkins S., and Burmeister M. 1998. 3&acute;-RACE: Skewed ratio of specific to 
  general PCR primers improves yield and specificity. <I>BioTechniques</I> 
  24:575-577. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Frohman M.A., 
  Dush M.K., and Martin G.R. 1988. Rapid production of full-length cDNAs from 
  rare transcripts: Amplification using a single gene-specific oligonucleotide 
  primer. <I>Proc. Natl. Acad. Sci.</I> 85:8998-9002. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Schaefer B.C. 
  1995. Revolutions in rapid amplification of cDNA ends: New strategies for 
  polymerase chain reaction cloning of full-length cDNA ends. <I>Anal. 
  Biochem.</I> 227:255-273. </FONT></LI></OL><BR><BR><BR><BR><BR><FONT 
face=Arial,Verdana,Helvetica size=1><STRONG>Copyright © 2000 by Cold Spring 
Harbor Laboratory Press. All rights reserved.</STRONG><BR>No part of these 
pages, either text or image may be used for any purpose other than personal use. 
Therefore, reproduction modification, storage in a retrieval system or 
retransmission, in any form or by any means, electronic, mechanical, or 
otherwise, for reasons other than personal use, is strictly prohibited without 
prior written permission.</FONT><BR><BR>
</td></tr></table>
</BODY></HTML>
